Not applicable (submitted trial is a bioavalability study in healthy participants). research hub

The pilot bioavailability study comparing the absorption of carbetocin (which is used as prevention of heavy bleeding after childbirth) in PABAL 100 μg/mL Solution for Injection when administered sublingually in the dose of 500 μg and intramuscularly in the dose of 100 μg.

This study is looking at how a medicine called carbetocin is absorbed by the body. Carbetocin helps prevent heavy bleeding after childbirth. Researchers want to compare two ways of giving it: under the tongue and by injection. This helps them understand which way works best.